Medical News

RSS

Idenix initiates IDX320 proof-of-concept study for HCV infection

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has initiated a 3-day proof-of-concept study of IDX320, a protease inhibitor for the treatment of hepatitis C virus (HCV) infection, under a Clinical Trial Application (CTA). The study is evaluating IDX320 in treatment-naive hepatitis C genotype 1-infected patients.

10 Jun 2010

Author Calvin Hill releases new book to share health and life-saving benefits of exercise program

Author Calvin Hill has released his new book Staying Fit after 60: Introducing the Exercise for Life Program to share the health and life-savings benefits of the program he has developed. He puts it bluntly: "I'm telling seniors, you can get old without feeling old."

10 Jun 2010

22 Midwest facilities named Centers of Excellence in accelerated partial breast irradiation

Twenty-two facilities in the Midwest have been named Centers of Excellence in accelerated partial breast irradiation (APBI) for their use of the SAVI® applicator, an advanced therapy for breast cancer as part of breast conservation therapy. The SAVI applicator can provide important advantages for women with early-stage breast cancer.

10 Jun 2010

Hooper Holmes' Heritage Labs division receives Certificate of Registration

Hooper Holmes today announced that its Heritage Labs division received a Certificate of Registration on May 28, 2010 and is now an ISO 13485:2003 registered company.

10 Jun 2010

$250 checks in the mail for Idaho Medicare beneficiaries in "Rx doughnut hole"

Older Idahoans living in fear of the cost of their next prescription drug may be getting some good news in the mail in the coming days; a $250 check to help. The checks are being mailed automatically to Idaho Medicare beneficiaries who fall into the dreaded Part D prescription drug coverage gap know as the "doughnut hole" – which leaves many stuck paying full price for their drugs, a cost many simply can't afford.

10 Jun 2010

Researchers develop new computer program for early diagnosis of Alzheimer's disease

Researchers of the University of Granada have developed a new computer program that allows early diagnosis of Alzheimer's disease through processed images. This new system has enhanced successful early diagnosis of Alzheimer's disease up to 90%, which is an important progress within this area of study.

10 Jun 2010

Onset Therapeutics expands sales force by over 50% in 2010

Onset Therapeutics, a specialty pharmaceutical company focused in dermatology, today announced the completion of the Company's latest sales force expansion initiative designed to provide national dermatology coverage to support the success of two recently launched products and the Company's rapidly growing pipeline of products in various stages of development.

10 Jun 2010

Quark Pharmaceuticals closes $10M private financing round

Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced the closing of a private financing by the existing investors of Quark totaling an aggregate of $10 million. The investors are funds of the prestigious SBI Holdings Group in Japan. In connection with the financing, Mr. Yoshitaka Kitao, CEO of SBI Holdings, Inc. and Mr. Robert Takeuchi, Director of SBI Investment Co., Ltd. will become members of the Quark board of directors.

10 Jun 2010

FDA grants Collegium Fast Track designation for COL-172 opioid formulation

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of COL-172 for the relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time.

10 Jun 2010

Raw and cooked gingers reduce pain associated with muscle injury by 24%: Reed's

Reed's, Inc., maker of the top-selling sodas in natural food stores nationwide, commented today on a recent study in The Journal of Medicine that both raw and cooked ginger reduce pain associated with muscle injury by about 24%, compared with placebo. The study was supported by the McCormick Science Institute.

10 Jun 2010

Boston Scientific's TAXUS Element Paclitaxel-Eluting Coronary Stent System launched in Europe

Boston Scientific Corporation today announced the market launch and first implants of its TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in the European Union and other CE Mark countries. The TAXUS Element Stent System is the Company's third-generation drug-eluting stent (DES) technology and incorporates a platinum chromium alloy with an innovative stent design and an advanced catheter delivery system. It received CE Mark approval last month, which included a specific indication for the treatment of diabetic patients.

10 Jun 2010

StemCells' GS2-M cell culture media formulation enhances pluripotency of human ES, iPS cells

StemCells, Inc. announced today that newly published independent research demonstrates that its GS2-M cell culture media formulation enhances the pluripotency of human embryonic stem and induced pluripotent stem cells. The Company's GS2-M medium has already been shown to enable the derivation and long-term maintenance of mouse iPS cells.

10 Jun 2010

Elsevier announces acquisition of Collexis

Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of assets from Collexis Holdings, Inc., a leading developer of semantic technology and knowledge discovery software.

10 Jun 2010

Veiovis, Medtral New Zealand announce new partnership

Veiovis, a leading global healthcare company in the medical travel industry, announces its new partnership with Medtral New Zealand, a provider of first-rate healthcare experiences in New Zealand. The partnership further expands Veiovis' network of medical travel options across Asia and the Pacific, and provides patients with access to New Zealand's finest private hospitals and specialists.

10 Jun 2010

PURE Bioscience's anhydrous SDC technology granted US patent

PURE Bioscience today announced that the United States Patent and Trademark Office issued patent number 7,732,486, which covers PURE's anhydrous silver dihydrogen citrate technology.

10 Jun 2010

PAREXEL experts to present on biopharmaceutical industry issues at 46th DIA

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that several of its experts will present on important industry issues at the Drug Information Association (DIA) 46th Annual Meeting, being held from June 13 – 17, 2010 in Washington, DC.

From Parexel 10 Jun 2010

Medical News

Idenix initiates IDX320 proof-of-concept study for HCV infection

Author Calvin Hill releases new book to share health and life-saving benefits of exercise program

22 Midwest facilities named Centers of Excellence in accelerated partial breast irradiation

Hooper Holmes' Heritage Labs division receives Certificate of Registration

$250 checks in the mail for Idaho Medicare beneficiaries in "Rx doughnut hole"

Researchers develop new computer program for early diagnosis of Alzheimer's disease

Onset Therapeutics expands sales force by over 50% in 2010

Quark Pharmaceuticals closes $10M private financing round

FDA grants Collegium Fast Track designation for COL-172 opioid formulation

Raw and cooked gingers reduce pain associated with muscle injury by 24%: Reed's

Boston Scientific's TAXUS Element Paclitaxel-Eluting Coronary Stent System launched in Europe

StemCells' GS2-M cell culture media formulation enhances pluripotency of human ES, iPS cells

Elsevier announces acquisition of Collexis

Veiovis, Medtral New Zealand announce new partnership

PURE Bioscience's anhydrous SDC technology granted US patent

PAREXEL experts to present on biopharmaceutical industry issues at 46th DIA

Bayard Advertising Agency selected as Recruitment Advertising Agency of Record for All About Staffing

Patient Home Monitoring retains Equicom for strategic investor relations

Gamma interferon wakes-up sleeping stem cells to produce immune system cells to fight invading bacteria

Emerging health care models and approaches discussed at 2010 Health Care Conference

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News